Skip to main content
. 2014 Sep 6;2014:bcr2013201238. doi: 10.1136/bcr-2013-201238

Figure 1.

Figure 1

(A) Patients’ glycaemic control: pre-SCT and post-SCT; (B) Patients’ insulin requirement: pre-SCT and post-SCT; (C) Patients’ FBS and PPBS levels: pre-SCT and post-SCT; (D) Patients’ serum (S.) C-peptide levels: pre-SCT and post-SCT (FBS, fasting blood sugar; HbA1c, glycosylated haemoglobin; PPBS, postprandial blood sugar; SCT, stem cell therapy).